Report Detail
Global Parathyroid Glands and Related Medicines Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4745982 |
- 28 September, 2026 |
- Global |
- 124 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Parathyroid Glands and Related Medicines market size was valued at US$ 1571 million in 2025 and is forecast to a readjusted size of US$ 2365 million by 2032 with a CAGR of 6.1% during review period.
The parathyroid glands are four small glands located in the neck that produce parathyroid hormone (PTH), which regulates the levels of calcium and phosphorus in the body. There are several drugs that can affect the function of the parathyroid gland or the levels of PTH in the body.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Parathyroid Glands and Related Medicines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Parathyroid Glands and Related Medicines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Parathyroid Glands and Related Medicines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Parathyroid Glands and Related Medicines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Parathyroid Glands and Related Medicines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Parathyroid Glands and Related Medicines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Parathyroid Glands and Related Medicines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CTTQ, Roche, Future Health Pharma, KPC Pharmaceuticals, Teva Pharmaceutical, Nantong Huashan Pharmaceutical, Teijin Pharma, Kyowa Kirin, Cheplapharm Arzneimittel, Jiangsu Hengrui Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Parathyroid Glands and Related Medicines market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Calcitriol
Alfacalcidol
Salmon Calcitonin
Paricalcitol
Other
Market segment by Application
Hospital
Clinic
Other
Major players covered
CTTQ
Roche
Future Health Pharma
KPC Pharmaceuticals
Teva Pharmaceutical
Nantong Huashan Pharmaceutical
Teijin Pharma
Kyowa Kirin
Cheplapharm Arzneimittel
Jiangsu Hengrui Pharmaceuticals
Novartis
Chongqing Yaoyou Pharmaceutical
AbbVie
Hebei Renhe Yikang Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Parathyroid Glands and Related Medicines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Parathyroid Glands and Related Medicines, with price, sales quantity, revenue, and global market share of Parathyroid Glands and Related Medicines from 2021 to 2026.
Chapter 3, the Parathyroid Glands and Related Medicines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Parathyroid Glands and Related Medicines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Parathyroid Glands and Related Medicines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Parathyroid Glands and Related Medicines.
Chapter 14 and 15, to describe Parathyroid Glands and Related Medicines sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Parathyroid Glands and Related Medicines Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Calcitriol
- 1.3.3 Alfacalcidol
- 1.3.4 Salmon Calcitonin
- 1.3.5 Paricalcitol
- 1.3.6 Other
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Parathyroid Glands and Related Medicines Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Other
- 1.5 Global Parathyroid Glands and Related Medicines Market Size & Forecast
- 1.5.1 Global Parathyroid Glands and Related Medicines Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Parathyroid Glands and Related Medicines Sales Quantity (2021-2032)
- 1.5.3 Global Parathyroid Glands and Related Medicines Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 CTTQ
- 2.1.1 CTTQ Details
- 2.1.2 CTTQ Major Business
- 2.1.3 CTTQ Parathyroid Glands and Related Medicines Product and Services
- 2.1.4 CTTQ Parathyroid Glands and Related Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 CTTQ Recent Developments/Updates
- 2.2 Roche
- 2.2.1 Roche Details
- 2.2.2 Roche Major Business
- 2.2.3 Roche Parathyroid Glands and Related Medicines Product and Services
- 2.2.4 Roche Parathyroid Glands and Related Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Roche Recent Developments/Updates
- 2.3 Future Health Pharma
- 2.3.1 Future Health Pharma Details
- 2.3.2 Future Health Pharma Major Business
- 2.3.3 Future Health Pharma Parathyroid Glands and Related Medicines Product and Services
- 2.3.4 Future Health Pharma Parathyroid Glands and Related Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Future Health Pharma Recent Developments/Updates
- 2.4 KPC Pharmaceuticals
- 2.4.1 KPC Pharmaceuticals Details
- 2.4.2 KPC Pharmaceuticals Major Business
- 2.4.3 KPC Pharmaceuticals Parathyroid Glands and Related Medicines Product and Services
- 2.4.4 KPC Pharmaceuticals Parathyroid Glands and Related Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 KPC Pharmaceuticals Recent Developments/Updates
- 2.5 Teva Pharmaceutical
- 2.5.1 Teva Pharmaceutical Details
- 2.5.2 Teva Pharmaceutical Major Business
- 2.5.3 Teva Pharmaceutical Parathyroid Glands and Related Medicines Product and Services
- 2.5.4 Teva Pharmaceutical Parathyroid Glands and Related Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Teva Pharmaceutical Recent Developments/Updates
- 2.6 Nantong Huashan Pharmaceutical
- 2.6.1 Nantong Huashan Pharmaceutical Details
- 2.6.2 Nantong Huashan Pharmaceutical Major Business
- 2.6.3 Nantong Huashan Pharmaceutical Parathyroid Glands and Related Medicines Product and Services
- 2.6.4 Nantong Huashan Pharmaceutical Parathyroid Glands and Related Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Nantong Huashan Pharmaceutical Recent Developments/Updates
- 2.7 Teijin Pharma
- 2.7.1 Teijin Pharma Details
- 2.7.2 Teijin Pharma Major Business
- 2.7.3 Teijin Pharma Parathyroid Glands and Related Medicines Product and Services
- 2.7.4 Teijin Pharma Parathyroid Glands and Related Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Teijin Pharma Recent Developments/Updates
- 2.8 Kyowa Kirin
- 2.8.1 Kyowa Kirin Details
- 2.8.2 Kyowa Kirin Major Business
- 2.8.3 Kyowa Kirin Parathyroid Glands and Related Medicines Product and Services
- 2.8.4 Kyowa Kirin Parathyroid Glands and Related Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Kyowa Kirin Recent Developments/Updates
- 2.9 Cheplapharm Arzneimittel
- 2.9.1 Cheplapharm Arzneimittel Details
- 2.9.2 Cheplapharm Arzneimittel Major Business
- 2.9.3 Cheplapharm Arzneimittel Parathyroid Glands and Related Medicines Product and Services
- 2.9.4 Cheplapharm Arzneimittel Parathyroid Glands and Related Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Cheplapharm Arzneimittel Recent Developments/Updates
- 2.10 Jiangsu Hengrui Pharmaceuticals
- 2.10.1 Jiangsu Hengrui Pharmaceuticals Details
- 2.10.2 Jiangsu Hengrui Pharmaceuticals Major Business
- 2.10.3 Jiangsu Hengrui Pharmaceuticals Parathyroid Glands and Related Medicines Product and Services
- 2.10.4 Jiangsu Hengrui Pharmaceuticals Parathyroid Glands and Related Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
- 2.11 Novartis
- 2.11.1 Novartis Details
- 2.11.2 Novartis Major Business
- 2.11.3 Novartis Parathyroid Glands and Related Medicines Product and Services
- 2.11.4 Novartis Parathyroid Glands and Related Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Novartis Recent Developments/Updates
- 2.12 Chongqing Yaoyou Pharmaceutical
- 2.12.1 Chongqing Yaoyou Pharmaceutical Details
- 2.12.2 Chongqing Yaoyou Pharmaceutical Major Business
- 2.12.3 Chongqing Yaoyou Pharmaceutical Parathyroid Glands and Related Medicines Product and Services
- 2.12.4 Chongqing Yaoyou Pharmaceutical Parathyroid Glands and Related Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Chongqing Yaoyou Pharmaceutical Recent Developments/Updates
- 2.13 AbbVie
- 2.13.1 AbbVie Details
- 2.13.2 AbbVie Major Business
- 2.13.3 AbbVie Parathyroid Glands and Related Medicines Product and Services
- 2.13.4 AbbVie Parathyroid Glands and Related Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 AbbVie Recent Developments/Updates
- 2.14 Hebei Renhe Yikang Pharmaceutical
- 2.14.1 Hebei Renhe Yikang Pharmaceutical Details
- 2.14.2 Hebei Renhe Yikang Pharmaceutical Major Business
- 2.14.3 Hebei Renhe Yikang Pharmaceutical Parathyroid Glands and Related Medicines Product and Services
- 2.14.4 Hebei Renhe Yikang Pharmaceutical Parathyroid Glands and Related Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 Hebei Renhe Yikang Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Parathyroid Glands and Related Medicines by Manufacturer
- 3.1 Global Parathyroid Glands and Related Medicines Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Parathyroid Glands and Related Medicines Revenue by Manufacturer (2021-2026)
- 3.3 Global Parathyroid Glands and Related Medicines Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Parathyroid Glands and Related Medicines by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Parathyroid Glands and Related Medicines Manufacturer Market Share in 2025
- 3.4.3 Top 6 Parathyroid Glands and Related Medicines Manufacturer Market Share in 2025
- 3.5 Parathyroid Glands and Related Medicines Market: Overall Company Footprint Analysis
- 3.5.1 Parathyroid Glands and Related Medicines Market: Region Footprint
- 3.5.2 Parathyroid Glands and Related Medicines Market: Company Product Type Footprint
- 3.5.3 Parathyroid Glands and Related Medicines Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Parathyroid Glands and Related Medicines Market Size by Region
- 4.1.1 Global Parathyroid Glands and Related Medicines Sales Quantity by Region (2021-2032)
- 4.1.2 Global Parathyroid Glands and Related Medicines Consumption Value by Region (2021-2032)
- 4.1.3 Global Parathyroid Glands and Related Medicines Average Price by Region (2021-2032)
- 4.2 North America Parathyroid Glands and Related Medicines Consumption Value (2021-2032)
- 4.3 Europe Parathyroid Glands and Related Medicines Consumption Value (2021-2032)
- 4.4 Asia-Pacific Parathyroid Glands and Related Medicines Consumption Value (2021-2032)
- 4.5 South America Parathyroid Glands and Related Medicines Consumption Value (2021-2032)
- 4.6 Middle East & Africa Parathyroid Glands and Related Medicines Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Parathyroid Glands and Related Medicines Sales Quantity by Type (2021-2032)
- 5.2 Global Parathyroid Glands and Related Medicines Consumption Value by Type (2021-2032)
- 5.3 Global Parathyroid Glands and Related Medicines Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Parathyroid Glands and Related Medicines Sales Quantity by Application (2021-2032)
- 6.2 Global Parathyroid Glands and Related Medicines Consumption Value by Application (2021-2032)
- 6.3 Global Parathyroid Glands and Related Medicines Average Price by Application (2021-2032)
7 North America
- 7.1 North America Parathyroid Glands and Related Medicines Sales Quantity by Type (2021-2032)
- 7.2 North America Parathyroid Glands and Related Medicines Sales Quantity by Application (2021-2032)
- 7.3 North America Parathyroid Glands and Related Medicines Market Size by Country
- 7.3.1 North America Parathyroid Glands and Related Medicines Sales Quantity by Country (2021-2032)
- 7.3.2 North America Parathyroid Glands and Related Medicines Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Parathyroid Glands and Related Medicines Sales Quantity by Type (2021-2032)
- 8.2 Europe Parathyroid Glands and Related Medicines Sales Quantity by Application (2021-2032)
- 8.3 Europe Parathyroid Glands and Related Medicines Market Size by Country
- 8.3.1 Europe Parathyroid Glands and Related Medicines Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Parathyroid Glands and Related Medicines Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Parathyroid Glands and Related Medicines Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Parathyroid Glands and Related Medicines Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Parathyroid Glands and Related Medicines Market Size by Region
- 9.3.1 Asia-Pacific Parathyroid Glands and Related Medicines Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Parathyroid Glands and Related Medicines Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Parathyroid Glands and Related Medicines Sales Quantity by Type (2021-2032)
- 10.2 South America Parathyroid Glands and Related Medicines Sales Quantity by Application (2021-2032)
- 10.3 South America Parathyroid Glands and Related Medicines Market Size by Country
- 10.3.1 South America Parathyroid Glands and Related Medicines Sales Quantity by Country (2021-2032)
- 10.3.2 South America Parathyroid Glands and Related Medicines Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Parathyroid Glands and Related Medicines Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Parathyroid Glands and Related Medicines Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Parathyroid Glands and Related Medicines Market Size by Country
- 11.3.1 Middle East & Africa Parathyroid Glands and Related Medicines Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Parathyroid Glands and Related Medicines Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Parathyroid Glands and Related Medicines Market Drivers
- 12.2 Parathyroid Glands and Related Medicines Market Restraints
- 12.3 Parathyroid Glands and Related Medicines Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Parathyroid Glands and Related Medicines and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Parathyroid Glands and Related Medicines
- 13.3 Parathyroid Glands and Related Medicines Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Parathyroid Glands and Related Medicines Typical Distributors
- 14.3 Parathyroid Glands and Related Medicines Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Parathyroid Glands and Related Medicines. Industry analysis & Market Report on Parathyroid Glands and Related Medicines is a syndicated market report, published as Global Parathyroid Glands and Related Medicines Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Parathyroid Glands and Related Medicines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
